Patents/Assignees

Forevertek Biotechnology Co., Ltd

11 patents in portfolio

US12552872utility2026
Humanized BCMA Antibody and BCMA-CAR-T Cells
0 cites
US12545742utility2026
Humanized CD37 and Bi-specific Cd19-humanized CD37 CAR-T Cells
0 cites
US12540195utility2026
Cs1-antibody and Anti-cs1-car-t Cells
0 cites
US12528873utility2026
Humanized BCMA Antibody and BCMA-CAR-T Cells
0 cites
US12448443utility2025
CS1 Antibody and Anti-cs1-car-t Cells
0 cites
US12173077utility2024
Humanized BCMA Antibody and BCMA-CAR-T Cells
0 cites
US12103970utility2024
CAR-T Cells with Humanized CD19 Scfv
0 cites
US12059436utility2024
BCMA-CAR-T Cells
0 cites
US12030957utility2024
Plap-car-effector Cells
0 cites
US11725053utility2023
Chimeric Antigen Receptors Comprising a Human Transferrin Epitope Sequence
0 cites
US11692034utility2023
CD47-CAR-T Cells
0 cites